Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Common sense.

[No authors listed]

Prescrire Int. 2012 Oct;21(131):228. No abstract available.

PMID:
23185841
2.

Paradoxical pinpoint pupils with asenapine.

Gill JS, Jambunathan S, Wong S, Wong A.

Asia Pac Psychiatry. 2015 Jun;7(2):230. doi: 10.1111/appy.12171. No abstract available.

PMID:
25923587
3.

A case of atypical antipsychotic-induced somnambulism: a class effect.

Dagan Y, Katz G.

J Clin Psychiatry. 2013 Apr;74(4):370. doi: 10.4088/JCP.12cr08283. No abstract available.

PMID:
23656842
4.

New drug information. Saphris.

Physician Assistants Prescribing Reference.

JAAPA. 2010 Mar;23(3):16. No abstract available.

PMID:
20232719
5.

Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.

[No authors listed]

Med Lett Drugs Ther. 2010 Feb 8;52(1331):9-10. Review. No abstract available.

PMID:
20216523
6.

A naturalistic retrospective review of weight gain in bipolar patients treated with second generation antipsychotics.

Worthington MA, El-Mallakh RS.

J Clin Psychopharmacol. 2015 Apr;35(2):192-3. doi: 10.1097/JCP.0000000000000271. No abstract available.

PMID:
25587693
7.

Asenapine.

Meltzer HY, Dritselis A, Yasothan U, Kirkpatrick P.

Nat Rev Drug Discov. 2009 Nov;8(11):843-4. doi: 10.1038/nrd3027.

PMID:
19876039
8.

â–¼Asenapine for bipolar I disorder?

[No authors listed]

Drug Ther Bull. 2012 Jun;50(6):69-72. doi: 10.1136/dtb.2012.06.0112.

PMID:
22700206
9.

ACS chemical neuroscience molecule spotlight on Saphris.

Hopkins CR.

ACS Chem Neurosci. 2010 Apr 21;1(4):263-4. doi: 10.1021/cn100022a. Erratum in: ACS Chem Neurosci. 2010 Jun 10;1(7):529.

10.

New drugs: asenapine, iloperidone, and bepotastine besilate.

Hussar DA, Abbas CA.

J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):107-10. doi: 10.1331/JAPhA.2010.10505. No abstract available.

PMID:
20097650
11.

Asenapine review, part II: clinical efficacy, safety and tolerability.

Citrome L.

Expert Opin Drug Saf. 2014 Jun;13(6):803-30. doi: 10.1517/14740338.2014.908183. Epub 2014 May 3. Review.

PMID:
24793161
12.

Asenapine: a new antipsychotic option.

Henry JM, Fuller MA.

J Pharm Pract. 2011 Oct;24(5):447-51. doi: 10.1177/0897190011422875.

PMID:
22156709
13.

Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2009 Dec;63(12):1762-84. doi: 10.1111/j.1742-1241.2009.02228.x. Epub 2009 Oct 14. Review.

PMID:
19840150
14.

Update on newer antipsychotic drugs.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2011 Apr;49(4):13-5. doi: 10.3928/02793695-20110311-99. Epub 2011 Mar 30.

PMID:
21446639
15.

Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.

Chwieduk CM, Scott LJ.

CNS Drugs. 2011 Mar;25(3):251-67. doi: 10.2165/11206700-000000000-00000. Review.

PMID:
21323396
16.

Asenapine: a clinical review of a second-generation antipsychotic.

Stoner SC, Pace HA.

Clin Ther. 2012 May;34(5):1023-40. doi: 10.1016/j.clinthera.2012.03.002. Epub 2012 Apr 10. Review.

PMID:
22494521
17.

Allergic reactions and sudden death with asenapine.

Masters KJ.

J Clin Psychiatry. 2012 May;73(5):720; author reply 720-1. doi: 10.4088/JCP.12lr07678. No abstract available.

PMID:
22697198
18.

Asenapine-associated myasthenic syndrome.

Hategan A, Bourgeois JA.

J Clin Psychopharmacol. 2015 Feb;35(1):107-8. doi: 10.1097/JCP.0000000000000235. No abstract available.

PMID:
25357196
19.

QTc prolongation with asenapine.

Kotasek F, Tibrewal P, Dhillon R.

Aust N Z J Psychiatry. 2014 Oct;48(10):961. doi: 10.1177/0004867414531832. Epub 2014 Apr 16. No abstract available.

PMID:
24740249
20.

Suicidal ideation associated with asenapine use: a report of 2 cases.

Jafferany M, Silverman MA.

J Clin Psychopharmacol. 2011 Aug;31(4):534-5. doi: 10.1097/JCP.0b013e3182223ae4. No abstract available.

PMID:
21720230

Supplemental Content

Support Center